Marrocolo F - Search Results

1

The Prostate Cancer Cells Resistant to Docetaxel as in vitro Model for Discovering MicroRNAs Predictive of the Onset of Docetaxel Resistance.

Bascetta L, Oliviero A, D'Aurizio R, Evangelista M, Mercatanti A, Pellegrini M, Marrocolo F, Bracarda S, Rizzo M. Bascetta L, et al. Among authors: marrocolo f. Int J Mol Sci. 2017 Jul 13;18(7):1512. doi: 10.3390/ijms18071512. Int J Mol Sci. 2017. PMID: 28703747 Free PMC article.

2

GOAL: an inverse toxicity-related algorithm for daily clinical practice decision making in advanced kidney cancer.

Bracarda S, Sisani M, Marrocolo F, Hamzaj A, del Buono S, De Simone V. Bracarda S, et al. Among authors: marrocolo f. Crit Rev Oncol Hematol. 2014 Mar;89(3):386-93. doi: 10.1016/j.critrevonc.2013.09.002. Epub 2013 Nov 13. Crit Rev Oncol Hematol. 2014. PMID: 24309065 Review.

3

Clinical implications for a treatment algorithm and differential indication to hormone therapy and chemotherapy options in metastatic castrate-resistant prostate cancer: a personal view.

Bracarda S, Sisani M, Marrocolo F, Hamzaj A, Del Buono S, Altavilla A. Bracarda S, et al. Among authors: marrocolo f. Expert Rev Anticancer Ther. 2014 Nov;14(11):1283-94. doi: 10.1586/14737140.2014.965686. Epub 2014 Oct 29. Expert Rev Anticancer Ther. 2014. PMID: 25353258 Review.

4

Comparing comparators: a look at control arms in kidney cancer studies over the years.

Bracarda S, Porta C, Sisani M, Marrocolo F, Paglino C, Hamzaj A, D Buono S, Sternberg CN. Bracarda S, et al. Among authors: marrocolo f. Br J Cancer. 2015 Jan 6;112(1):14-9. doi: 10.1038/bjc.2014.240. Epub 2014 Nov 6. Br J Cancer. 2015. PMID: 25375270 Free PMC article. Review.

5

Immunologic checkpoints blockade in renal cell, prostate, and urothelial malignancies.

Bracarda S, Altavilla A, Hamzaj A, Sisani M, Marrocolo F, Del Buono S, Danielli R. Bracarda S, et al. Among authors: marrocolo f. Semin Oncol. 2015 Jun;42(3):495-505. doi: 10.1053/j.seminoncol.2015.02.004. Epub 2015 Feb 12. Semin Oncol. 2015. PMID: 25965369 Review.

6

Secreted miR-210-3p, miR-183-5p and miR-96-5p reduce sensitivity to docetaxel in prostate cancer cells.

Canovai M, Evangelista M, Mercatanti A, D'Aurizio R, Pitto L, Marrocolo F, Casieri V, Pellegrini M, Lionetti V, Bracarda S, Rizzo M. Canovai M, et al. Among authors: marrocolo f. Cell Death Discov. 2023 Dec 8;9(1):445. doi: 10.1038/s41420-023-01696-4. Cell Death Discov. 2023. PMID: 38065937 Free PMC article.

7

Gemcitabine and cisplatin combination in early-stage non-small-cell lung cancer.

Crinò L, Calandri C, Maestri A, Marrocolo F. Crinò L, et al. Among authors: marrocolo f. Oncology (Williston Park). 2001 Mar;15(3 Suppl 6):40-2. Oncology (Williston Park). 2001. PMID: 11301847 Free article. Review.

8

Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer.

Novello S, Galli L, Antonuzzo A, Crinó L, Pozzi E, Selvaggi G, Ricci S, Marrocolo F, Darwish S, Sorbolini S, Tonato M, Scagliotti GV. Novello S, et al. Among authors: marrocolo f. Lung Cancer. 2001 Nov;34(2):261-9. doi: 10.1016/s0169-5002(01)00238-0. Lung Cancer. 2001. PMID: 11679185 Clinical Trial.

9

[Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer: the MA-17 study].

Gori S, Anastasi P, Marrocolo F. Gori S, et al. Among authors: marrocolo f. Suppl Tumori. 2004 Jul-Aug;3(4):S27-31. Suppl Tumori. 2004. PMID: 15206206 Italian. No abstract available.

10

[Orbital embryonal rhabdomyosarcoma in adults. Report of 2 cases].

Marucci G, Galliani E, Marrocolo F, Foschini MP. Marucci G, et al. Among authors: marrocolo f. Pathologica. 1999 Dec;91(6):459-65. Pathologica. 1999. PMID: 10783642 Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page